Perfect
Seed Round in 2025
Perfect is a generative artificial intelligence-powered talent finding platform that assists organizations in filling staff vacancies. By mapping the career graphs of millions of technology-focused professionals, Perfect enables companies to identify and engage potential candidates effectively. The platform streamlines the recruiting process, making it easier for organizations to connect with qualified individuals suited for their specific needs. Perfect operates from a physical address, emphasizing its commitment to providing personalized recruiting services.
Finout is a cloud cost management platform designed to help companies optimize and control their cloud expenditures. It offers tools for DevOps, FinOps, Site Reliability Engineering (SRE), and cloud cost observability. The platform enables users to gain insights into their spending on various aspects, including cost of goods sold (COGS) and research and development. By breaking down costs per tenant, Finout allows finance and development teams to better understand their bills and unit economics. This comprehensive approach empowers organizations to regain control over their cloud costs, facilitating more informed decision-making and cost reduction from multiple perspectives.
HomeThrive
Series B in 2024
HomeThrive offers care management services for elderly individuals, combining digital platforms with expert coaching and personal assistance. It aims to help older adults live independently at home while reducing the burden on family caregivers.
Quantum Source
Series A in 2024
Quantum Source is developing a novel photonic quantum architecture for fault-tolerant, practical quantum computers. Their approach uses chip-based photon-atom gates to enable deterministic exchange of quantum information between photonic and atomic qubits. This allows for scalable quantum systems with reduced complexity, footprint, power consumption, and cost compared to other implementations.
Guardoc Health
Seed Round in 2024
Guardoc Health specializes in clinical risk management, offering an AI-driven platform that integrates with electronic healthcare records. This platform identifies and addresses errors, gaps, and discrepancies in clinical charting, enabling hospitals to meet regulatory requirements, improve patient care, and optimize revenue management.
Finout is a cloud cost management platform designed to help companies optimize and control their cloud expenditures. It offers tools for DevOps, FinOps, Site Reliability Engineering (SRE), and cloud cost observability. The platform enables users to gain insights into their spending on various aspects, including cost of goods sold (COGS) and research and development. By breaking down costs per tenant, Finout allows finance and development teams to better understand their bills and unit economics. This comprehensive approach empowers organizations to regain control over their cloud costs, facilitating more informed decision-making and cost reduction from multiple perspectives.
Variantyx
Series D in 2024
Variantyx Inc. is a biotechnology company headquartered in Framingham, Massachusetts, that specializes in whole genome sequencing-based diagnostic testing. Founded in 2014, the company offers a comprehensive platform that includes its Genomic Unity® test, which identifies and reports all major types of genetic variants from a single patient sample. This test is designed to diagnose rare inherited disorders, providing a more efficient alternative to traditional genetic testing methods. Variantyx's technology enables hospitals and commercial laboratories to accurately analyze whole genome sequenced data, facilitating a better understanding of a patient's genetic makeup and leading to optimized treatment recommendations. The company's focus on genomic intelligence positions it at the forefront of precision medicine.
Knostic
Pre Seed Round in 2024
Knostic is a developer of a risk management and governance platform specifically designed for enterprise large language models (LLMs). The company's software addresses the challenges associated with LLMs, particularly in managing their tendencies to generate excessive or inappropriate responses. Knostic provides essential access controls that enable enterprises to deploy LLMs effectively while ensuring security, safety, and the preservation of value. Through its knowledge-centric capabilities, Knostic facilitates AI-powered innovation, allowing organizations to harness the potential of LLMs in a responsible and efficient manner.
Salvador Technologies
Seed Round in 2023
Salvador Technologies specializes in developing system solutions for recovering computers from cyber attacks. Their products include cyber recovery stations, USB devices for organization-wide recovery, workstation-specific instant recovery tools, and pre-configured servers. The company leverages over a decade of experience from its founders in Israel's National Cyber Unit and elite intelligence corps to provide robust cybersecurity solutions.
Variantyx
Venture Round in 2023
Variantyx Inc. is a biotechnology company headquartered in Framingham, Massachusetts, that specializes in whole genome sequencing-based diagnostic testing. Founded in 2014, the company offers a comprehensive platform that includes its Genomic Unity® test, which identifies and reports all major types of genetic variants from a single patient sample. This test is designed to diagnose rare inherited disorders, providing a more efficient alternative to traditional genetic testing methods. Variantyx's technology enables hospitals and commercial laboratories to accurately analyze whole genome sequenced data, facilitating a better understanding of a patient's genetic makeup and leading to optimized treatment recommendations. The company's focus on genomic intelligence positions it at the forefront of precision medicine.
AI21 Labs
Series C in 2023
AI21 Labs is an Israeli artificial intelligence company that develops generative AI and large language models along with tools to understand and generate natural language. Founded in 2017 and based in Tel Aviv-Yafo, it provides AI-based writing and reading assistance that understands context and meaning, including a writing companion that can rephrase text to convey the intended message and generate summaries. The company's tools help users read more efficiently, analyze and visualize complex knowledge structures, and apply deep learning and NLP to transform writing and comprehension for businesses and individuals.
Gina Life
Seed Round in 2023
Gina Life is femtech company developing a platform of biomarkers strategy supported by AI for early detection in women’s health space.
QuantHealth
Series A in 2023
QuantHealth is a company focused on enhancing drug development through artificial intelligence-based software. This software is designed to conduct patient-centric simulations that accelerate and de-risk the drug development process. By integrating diverse data points from the clinical and drug development landscape, QuantHealth predicts patient responses to both existing and new therapies. This capability allows pharmaceutical and biotechnology firms to explore various scenarios within their clinical trials, optimizing trial designs and improving the likelihood of successful outcomes. Ultimately, QuantHealth's solutions facilitate the discovery of new clinical opportunities and strategies for optimizing drug development.
Surge Therapeutics
Series B in 2023
SURGE Therapeutics is a biotechnology company focused on enhancing cancer treatment outcomes through innovative immunotherapy solutions. It has developed a proprietary injectable biodegradable hydrogel designed to deliver cancer therapeutics in a prolonged and localized manner. This technology enables targeted release of immunotherapy agents at the surgical site following tumor resection, allowing for more effective treatment administration. By optimizing the timing and location of drug delivery, SURGE Therapeutics aims to improve patient survival rates and minimize systemic side effects, representing a significant advancement in the field of cancer care.
LocalizeOS
Series A in 2023
LocalizeOS is an AI-powered operating system tailored for the residential real estate industry. It offers a suite of products, including LocalizeAI, LocalizeBI, LocalizeMarketplace, and LocalizeHQ, empowering brokers to achieve scalable success by effectively connecting with qualified buyers through proactive AI tools.
Tomorrow.io
Series E in 2023
Tomorrow.io develops a SaaS weather intelligence platform that provides real-time, location-specific weather forecasts tailored to industries affected by weather. The platform helps organizations predict business impacts of weather, streamline communication, and optimize operations to improve efficiency and margins. It combines traditional meteorology data with signals from wireless networks, connected vehicles, satellites, street cameras, and other sources to deliver micro-forecast information. It serves clients across sectors worldwide, enabling countries, businesses, and individuals to manage weather-related challenges and improve decision-making. The company operates in North America, Latin America, Europe, and Asia.
Vertos Medical
Series C in 2023
Vertos Medical Inc. is a medical device company specializing in minimally invasive treatments for lumbar spinal stenosis, a common spinal condition. Founded in 2005 and headquartered in Aliso Viejo, California, the company develops and markets its mild device, which provides an outpatient treatment option that is fluoroscopically guided and does not require implants. This device encompasses a range of instruments including tissue sculptors, surgical clamps, and bone sculpters, allowing physicians to effectively relieve pressure on the spinal nerves and restore mobility with local anesthesia. Vertos Medical’s innovative approach offers patients a less invasive option compared to traditional lumbar decompression surgeries, making significant advancements in spinal healthcare.
Incredo, a global food-tech company formerly known as DouxMatok, specializes in developing innovative technologies aimed at reducing sugar consumption while maintaining the sensory qualities of sweetness. Founded in 2014 and headquartered in Petach-Tikva, Israel, Incredo has created a proprietary solution that enhances the sweetness of real cane sugar without the undesirable aftertaste, allowing for a significant reduction in sugar content in various food products. The company's approach ensures that consumers can enjoy their favorite foods and snacks with less sugar, without sacrificing taste, mouthfeel, or texture. This focus on healthier consumption aligns with growing consumer demand for nutritious alternatives in the food industry.
Patient 21
Series C in 2023
Patient21 operates a health platform focused on improving the doctor-patient connection, which they view as essential for effective healthcare. The company aims to modernize the healthcare experience by addressing the fragmented and outdated processes currently prevalent in the industry. By leveraging technology, Patient21 enhances dental clinics with management software that streamlines administrative tasks such as appointment scheduling and patient data management. They also provide electronic health records (EHR) to healthcare professionals, which helps improve diagnostic quality and reduce costs. Through these innovations, Patient21 seeks to facilitate better decision-making for both patients and physicians, ultimately promoting a more personalized and collaborative approach to healthcare.
Magenta Medical
Venture Round in 2023
Magenta Medical is a private medical device company based in Kadima, Israel, founded in 2012. It develops catheter-based therapies for acute decompensated heart failure, including a self-expanding heart pump and temporary venous catheter-based treatments designed to relieve renal venous congestion. The technology enables quicker and safer removal of excess fluid and salt while protecting renal function, addressing a core pathophysiological element of acute heart failure and related conditions.
Quantum Source
Seed Round in 2023
Quantum Source is developing a novel photonic quantum architecture for fault-tolerant, practical quantum computers. Their approach uses chip-based photon-atom gates to enable deterministic exchange of quantum information between photonic and atomic qubits. This allows for scalable quantum systems with reduced complexity, footprint, power consumption, and cost compared to other implementations.
Volumez is a provider of Data Infrastructure as a Service (DIaaS), offering a platform that integrates and orchestrates cloud resources to create customized data infrastructures suited to specific workload requirements. The platform is designed for data-intensive applications, ensuring performance, resilience, scalability, and cost efficiency across any cloud environment. With its innovative architecture and controller-less design, Volumez simplifies the deployment of storage solutions and dynamically adjusts to the evolving needs of businesses. This results in a predictable and composable DIaaS that delivers high performance and ultra-low latency while maintaining enterprise-grade data resilience at optimized costs. The company’s services are accessible through major cloud marketplaces, including AWS, Azure, and Oracle Cloud, facilitating easier management of both public and private cloud resources.
Zorro is an insurtech company offering health insurance and services. It helps employers reduce costs by providing personalized, valued benefits tailored to employee needs.
Protai is a biotech company that uses proteomics and artificial intelligence to advance drug discovery. Its platform combines mass spectrometry proteomics with protein-focused datasets and machine learning to identify proteo-forms, including post-translational modifications, and map protein–protein interactions and quantification. By leveraging these insights, the platform aims to improve the design and validation of drug candidates, accelerate discovery, and potentially lower development costs. The approach translates complex biological data into actionable insights to reshape outcomes in the development of therapies for challenging diseases.
Via Transportation Inc. is a company that develops innovative public mobility solutions, focusing on on-demand and pre-scheduled transit. Founded in 2012 and headquartered in New York, Via serves a diverse range of clients, including public transit agencies, cities, universities, corporations, and school districts. The company's mobile app connects passengers traveling in the same direction, allowing them to share premium vehicles and enhancing the efficiency of public transit systems. Via aims to transform traditional, rigid transit systems into dynamic networks by integrating its technology with existing public transportation infrastructure. This approach not only reduces operational costs and traffic congestion but also minimizes single-occupancy trips and carbon emissions, providing more accessible and environmentally friendly transit options. Via operates both in the United States and Europe through partnerships, including a joint venture with Mercedes-Benz Vans.
PayEm is a provider of a spend and procurement management platform designed to enhance efficiency and transparency for finance teams. The platform automates the entire process from request to reconciliation, enabling finance professionals to capture invoices, create bills, and schedule payments globally in various currencies. By integrating credit card functionalities and a payment system, PayEm allows users to monitor employee spending and seamlessly sync data with accounting software. This automation reduces tedious tasks, minimizes friction, and provides real-time visibility across departments, teams, and subsidiaries. As a result, finance teams can focus on strategic objectives while effectively managing expenses and reporting.
Lumen is a company that has developed a portable device and accompanying app that measures an individual's metabolism through a single breath. This technology provides users with real-time insights into their metabolic health, enabling them to receive personalized nutrition recommendations tailored to their unique metabolic data. By using Lumen, individuals can better understand their dietary needs and manage their weight effectively, whether their goals are weight loss, performance optimization, or overall wellness. The company is comprised of a diverse team of scientists, researchers, engineers, and designers dedicated to transforming how people approach their health through improved metabolic awareness.
Founded in 2021, Sepana develops advanced search technologies for the decentralized web. Its platform enables developers to integrate search-as-a-service functionality into their applications, facilitating the discovery of Web3 content.
Surge Therapeutics
Series A in 2022
SURGE Therapeutics is a biotechnology company focused on enhancing cancer treatment outcomes through innovative immunotherapy solutions. It has developed a proprietary injectable biodegradable hydrogel designed to deliver cancer therapeutics in a prolonged and localized manner. This technology enables targeted release of immunotherapy agents at the surgical site following tumor resection, allowing for more effective treatment administration. By optimizing the timing and location of drug delivery, SURGE Therapeutics aims to improve patient survival rates and minimize systemic side effects, representing a significant advancement in the field of cancer care.
DriveNets
Series C in 2022
DriveNets is a software company founded in 2015 that builds cloud‑native networking solutions for communications service providers. Its flagship product, Network Cloud, disaggregates core and edge infrastructure, replacing traditional hardware with a software‑centric routing stack that runs on standard networking white boxes. The platform delivers a shared data‑path control plane, central management, and northbound interfaces that integrate with third‑party tools. DriveNets supports large‑scale network modernization and AI workloads, enabling telecom operators and data centers to increase agility, cut operating costs, and optimize performance for demanding applications. The company is headquartered in Ra’anana, Israel, with an additional office in Red Bank, New Jersey.
AI21 Labs
Series B in 2022
AI21 Labs is an Israeli artificial intelligence company that develops generative AI and large language models along with tools to understand and generate natural language. Founded in 2017 and based in Tel Aviv-Yafo, it provides AI-based writing and reading assistance that understands context and meaning, including a writing companion that can rephrase text to convey the intended message and generate summaries. The company's tools help users read more efficiently, analyze and visualize complex knowledge structures, and apply deep learning and NLP to transform writing and comprehension for businesses and individuals.
Quantum Source
Seed Round in 2022
Quantum Source is developing a novel photonic quantum architecture for fault-tolerant, practical quantum computers. Their approach uses chip-based photon-atom gates to enable deterministic exchange of quantum information between photonic and atomic qubits. This allows for scalable quantum systems with reduced complexity, footprint, power consumption, and cost compared to other implementations.
Visby Medical
Series E in 2022
Visby Medical is a diagnostics company developing PCR-based testing devices and a mobile-enabled health care platform for infectious diseases. Its device platform enables PCR-based diagnostics with results in under 30 minutes and requires no additional instruments or maintenance, supporting point-of-care testing during a single visit. The company pursues a human-centric, technology-first approach to device development and also provides services related to health information, risk assessment, electronic medical records, data privacy and security, data analytics, and remote medical advice for governments, national-level NGOs, and private health providers. Founded in 2008 and based in San Jose, California, Visby Medical aims to improve patient outcomes by enabling rapid, accurate tests at the point of care.
Finout is a cloud cost management platform designed to help companies optimize and control their cloud expenditures. It offers tools for DevOps, FinOps, Site Reliability Engineering (SRE), and cloud cost observability. The platform enables users to gain insights into their spending on various aspects, including cost of goods sold (COGS) and research and development. By breaking down costs per tenant, Finout allows finance and development teams to better understand their bills and unit economics. This comprehensive approach empowers organizations to regain control over their cloud costs, facilitating more informed decision-making and cost reduction from multiple perspectives.
Indoor Robotics
Series A in 2022
Founded in 2018, Indoor Robotics designs and develops Tando, an AI-powered patrol drone for indoor security and inspection missions. Its unique features include independent AI-based navigation and patented ceiling docking, providing real-time coverage with predictive analysis to minimize false alarms.
Nas.io
Funding Round in 2022
Nas.io helps anyone go from idea to revenue in 1 minute with AI. Create digital products, build engaged communities, and automate marketing—all in one intuitive platform.
Nas.io puts community first. Challenges, events, social feed, and memberships drive revenue growth for your business. Join 200k+ entrepreneurs and build your dream digital business with AI in 1 minute, no technical skills required.
HomeThrive
Series B in 2022
HomeThrive offers care management services for elderly individuals, combining digital platforms with expert coaching and personal assistance. It aims to help older adults live independently at home while reducing the burden on family caregivers.
Masterschool
Seed Round in 2022
Masterschool is a global network of success-based online training programs focused on developing careers in technology. The company partners with industry leaders, businesses, and creators to provide comprehensive educational opportunities that include personal mentorship and professional guidance. Masterschool operates on a unique model where students pay tuition fees only upon securing employment, making it an accessible option for individuals seeking to acquire the necessary skills for a successful career in tech. Through its robust network of industry connections, Masterschool facilitates growth and learning opportunities for aspiring tech professionals.
Optibus leverages the power of machine learning and optimization algorithms to redefine the way mass-transportation is planned and operated. Optibus’ disruptive technology drive some of the most complex transportation operations worldwide, helping to improve the quality of service, increase efficiencies, save money, and streamline operations.
Komodor is a platform that automates Kubernetes operations. It ingests daily Kubernetes events, tracks deployments, configurations, and code changes, correlating them with cluster status for clear understanding of system events.
Founded in 2017, Nexite operates a platform that enhances physical retail by providing real-time item-level insights. Its key offerings include tiny, battery-free NanoBT tags that enable inventory tracking, transparency, and business intelligence from manufacturing to the customer's home. This empowers retailers and brands to create new revenue streams, improve stock management, and enhance shopping experiences.
Grappa is a company that has developed an authenticated digital reputation network aimed at showcasing individual achievements and skills. Through its platform, Grappa offers badges that symbolize an individual's professional journey, effectively representing their competencies and milestones. This innovative approach allows businesses to evaluate potential candidates based on these badges, facilitating a more informed selection process. By highlighting achievements in a structured format, Grappa enhances the visibility of skills, supporting both job seekers and employers in identifying the right fit for various roles.
ARMO offers a runtime-powered, Kubernetes-driven, Cloud Security Platform.
ARMO Platform is the only platform that continuously minimizes cloud attack surface based on runtime insights, while actively detecting and responding to cyberattacks with real risk context.
Today there is a vicious cycle of endless back and forth between security and DevOps/Engineering teams. Thousands of security tickets are opened, and an overwhelming number of real time alerts are triggered, but the majority of them are ignored or remain unsolved, and no real security is achieved.
The use of runtime insights and Kubernetes context is crucial for securing the cloud and breaking this cycle.
ARMO Platform uses an eBPF-based runtime sensor to record application behavior and related activities. The recorded baseline is then enriched with relevant context from Kubernetes events, CI/CD data, cloud data and containers’ data. The result is an Application Profile DNA (APDTM), which is the holistic baseline for applications’ normal behavior, configuration, and policies.
Using APDTM, ARMO Platform enables automatic and continuous cloud security posture management to harden cloud-native infrastructure and workloads and to remediate security risks without breaking applications. By detecting and responding to anomalous behaviors, malicious activities and malware, ARMO cloud detection & response (CDR) protects workloads from cyberattacks at runtime. It instantly detects and responds to them without flooding teams with alerts.
ARMO Platform enables DevOps, security, and platform teams to eliminate the security noise in their clusters from thousands of irrelevant alerts and focus on the most important and exploitable threats. This allows them to shift from managing hypothetical security issues to mitigating actual risks and providing them with the means to remediate them.
ARMO Platform protects any type of cloud and Kubernetes deployments: managed, on-premises, and air-gapped.
ARMO is an open-source-driven company and the creator of Kubescape, a leading open-source Kubernetes security project, now an official CNCF project. Kubescape is deployed and tested across over 100K clusters in environments as small as a few workloads, and up to enterprise scales with over 50K running workloads.
Founded in 2016, D-ID specializes in AI-driven video content creation. Its platform uses artificial intelligence to generate dynamic videos from images, text, and audio, enabling businesses to produce scalable, personalized narratives cost-effectively without traditional video production teams.
Anywell is a pioneering provider of Workspace-as-a-Service solutions aimed at fostering a more human-centric and flexible work environment. The company enables businesses to offer their employees a hybrid work experience by granting access to inspiring workspaces within local communities through an app-based platform. Anywell enhances this experience by providing a range of amenities, including Wi-Fi, reservation systems, public and private seating options, technology kits, meal plans, and wallet-less payment solutions. Through its innovative approach, Anywell seeks to support companies and their employees in creating a work culture that accommodates diverse needs and preferences.
Visby Medical
Series E in 2022
Visby Medical is a diagnostics company developing PCR-based testing devices and a mobile-enabled health care platform for infectious diseases. Its device platform enables PCR-based diagnostics with results in under 30 minutes and requires no additional instruments or maintenance, supporting point-of-care testing during a single visit. The company pursues a human-centric, technology-first approach to device development and also provides services related to health information, risk assessment, electronic medical records, data privacy and security, data analytics, and remote medical advice for governments, national-level NGOs, and private health providers. Founded in 2008 and based in San Jose, California, Visby Medical aims to improve patient outcomes by enabling rapid, accurate tests at the point of care.
Variantyx
Series C in 2022
Variantyx Inc. is a biotechnology company headquartered in Framingham, Massachusetts, that specializes in whole genome sequencing-based diagnostic testing. Founded in 2014, the company offers a comprehensive platform that includes its Genomic Unity® test, which identifies and reports all major types of genetic variants from a single patient sample. This test is designed to diagnose rare inherited disorders, providing a more efficient alternative to traditional genetic testing methods. Variantyx's technology enables hospitals and commercial laboratories to accurately analyze whole genome sequenced data, facilitating a better understanding of a patient's genetic makeup and leading to optimized treatment recommendations. The company's focus on genomic intelligence positions it at the forefront of precision medicine.
Sayata Labs Ltd., established in 2016 and headquartered in Tel Aviv, Israel, specializes in data-driven cybersecurity solutions for the insurance industry. The company's platform, Sayata, streamlines the commercial risk placement process for brokers and carriers, enabling them to issue quotes, bind, and issue policies swiftly and efficiently. By leveraging AI technology, Sayata provides actionable insights to help manage cyber risks, thereby facilitating rapid and profitable growth of cyber insurance books. As of now, over 1,000 users across 75 brokerages and carriers utilize Sayata's platform to expand their commercial risk portfolios.
Lexense
Seed Round in 2022
Lexense is a provider of digital legal services aimed at enhancing access to justice. The company offers a data-driven platform that simplifies the management of civil claims, allowing clients to effectively exercise their legal rights. By integrating advanced technology with a success-based pricing model, Lexense strives to make quality legal assistance accessible and affordable for individuals and businesses alike. Its comprehensive end-to-end solution combines funding, technology, and expertise, enabling efficient resolution of civil cases while empowering users to navigate the court system more easily.
Protai is a biotech company that uses proteomics and artificial intelligence to advance drug discovery. Its platform combines mass spectrometry proteomics with protein-focused datasets and machine learning to identify proteo-forms, including post-translational modifications, and map protein–protein interactions and quantification. By leveraging these insights, the platform aims to improve the design and validation of drug candidates, accelerate discovery, and potentially lower development costs. The approach translates complex biological data into actionable insights to reshape outcomes in the development of therapies for challenging diseases.
Frontegg LTD. is a Tel-Aviv-based company that specializes in developing a user management platform aimed at enabling software as a service (SaaS) businesses. Founded in 1982, Frontegg provides a comprehensive solution that allows SaaS companies to easily integrate and manage essential user infrastructure, from basic authentication to complex multi-tenancy and fine-grained authorization. Its platform facilitates rapid integration into existing web applications with minimal coding, supporting a variety of frontend and backend frameworks. Frontegg also offers features such as a self-service admin portal, subscription enforcement, and single sign-on capabilities, enhancing the user experience for both personal and organizational accounts. By embedding its interfaces within applications, Frontegg provides a customer-facing management interface while equipping developers with powerful SDKs and APIs to maintain full control over their data.
Founded in 2019, Swimm develops software for onboarding and training developers. Its platform generates up-to-date internal documentation within integrated development environments, enhancing knowledge sharing among developer teams.
Lumigo Ltd. is a technology company that focuses on developing a serverless intelligence platform designed to assist developers in monitoring, troubleshooting, and optimizing serverless applications. Founded in 2018 and headquartered in Tel Aviv, Israel, Lumigo's platform leverages data analysis to learn the normal behavior of serverless applications, providing live visual maps and insights that help identify and resolve issues quickly. The platform offers end-to-end visibility and traceability, allowing operations teams to understand each request and pinpoint the root causes of problems, including interactions with adjacent services like databases and storage. By enabling actionable alerts based on user behavior analytics, Lumigo empowers organizations to prevent service disruptions and enhance the reliability of their cloud applications.
Oshi specializes in developing and producing plant-based fish fillets using advanced technology. Their mission is to create delicious, nutritious, and sustainable alternatives to traditional fish products.
Aquant develops an AI-driven platform that maximizes equipment uptime by predicting faults, diagnosing service issues, and optimizing van stock. Serving industries such as life sciences, capital equipment, and food service, Aquant's solution aggregates real-time signals, identifies failures, and provides actionable insights to enhance operational efficiency.
Speedata develops specialized processors for accelerating big data analytics across various industries. Its core product is the Analytics Processing Unit (APU), designed to optimize datacenter and cloud-based database workloads, significantly enhancing performance while reducing costs, power consumption, and space requirements.
Totango develops a customer success platform that helps businesses drive customer adoption, retention, expansion, and referrals. Its solutions include automated workflows, engagement features, and AI-powered predictive analytics to monitor customer health and proactively reduce churn. Totango serves leading customer success teams worldwide, including SAP and GitHub.
StreamElements
Series B in 2021
StreamElements is a company based in Tel Aviv, Israel, founded in 2016. It specializes in developing a web-based platform tailored for live content creators, offering tools for monetization, audience management, and community growth. The platform allows creators to display unblockable ads, collect donations, and reward viewers with loyalty points. Key features include a stream dashboard, overlay manager, chat statistics, leaderboard, spam filters, and custom stream pages. StreamElements also facilitates revenue generation through viewer purchases using currency earned by watching streams. Additionally, the company provides cloud-based overlays, alerts, chatbots, loyalty programs, sponsorships, and brand-safe moderation services. It supports creators across various platforms like Twitch, YouTube, Twitter, and TikTok, connecting them with brands for performance marketing campaigns.
PayEm is a provider of a spend and procurement management platform designed to enhance efficiency and transparency for finance teams. The platform automates the entire process from request to reconciliation, enabling finance professionals to capture invoices, create bills, and schedule payments globally in various currencies. By integrating credit card functionalities and a payment system, PayEm allows users to monitor employee spending and seamlessly sync data with accounting software. This automation reduces tedious tasks, minimizes friction, and provides real-time visibility across departments, teams, and subsidiaries. As a result, finance teams can focus on strategic objectives while effectively managing expenses and reporting.
Tulip Interfaces
Series C in 2021
Tulip Interfaces is a technology company that creates shop‑floor applications for the manufacturing sector. Its no‑code platform integrates sensor data, digital work instructions, real‑time visualization, and operator inputs to connect existing equipment and streamline operations. The solution is used by firms in consumer electronics, pharmaceuticals, apparel, medical devices, aerospace, defense, automotive, and contract manufacturing to improve productivity, quality, and operational visibility. Founded in 2012, the company is headquartered in Somerville, Massachusetts.
Salvador Technologies
Seed Round in 2021
Salvador Technologies specializes in developing system solutions for recovering computers from cyber attacks. Their products include cyber recovery stations, USB devices for organization-wide recovery, workstation-specific instant recovery tools, and pre-configured servers. The company leverages over a decade of experience from its founders in Israel's National Cyber Unit and elite intelligence corps to provide robust cybersecurity solutions.
Connie Health
Series A in 2021
Connie Health assists older Americans in making informed decisions about their healthcare by providing medical advisory services through a technology platform paired with local Medicare experts. They help individuals optimize prescription costs, find healthcare providers, and navigate insurance plan benefits.
Tailor Brands
Series C in 2021
Founded in 2014, Tailor Brands operates an online platform that simplifies business creation and management. It offers logo design, branding tools for business cards and letterheads, along with personalized guidance on utilizing various business-building tools.
Silk is a technology company that focuses on enhancing AI innovation by providing real-time access to production data in the cloud. It integrates high-performance cloud storage into AI workflows, allowing organizations to improve innovation while ensuring performance, reliability, and control over their enterprise data. Silk's agile data delivery system eliminates the need to copy production data, thereby increasing flexibility and enabling the utilization of production data for Generative AI applications. The company holds over 20 technology patents, which support its mission to help customers maximize the advantages of the public cloud with speed and ease. Silk is headquartered near Boston, Massachusetts.
Gloww provides a platform for planning, designing, and hosting live video experiences with a focus on attendee engagement. It offers customizable templates or the option to create from scratch, supports importing decks and media assets, and includes a library of images, HD videos, and music to build interactive, content-rich sessions. The product aims to reinvent the live interaction experience for hosts and participants by enabling planning, creation, and running of highly interactive, content-first live video sessions.
Venn Ltd. is a company that specializes in co-living facilities, providing private and shared living and working arrangements. Founded in 2015 and headquartered in Tel Aviv, Israel, with additional offices in Brooklyn, New York, and Berlin, Germany, Venn focuses on fostering community engagement and social impact. The company manages homes and creates shared spaces while supporting local business initiatives and services. Its platform facilitates programs and events that encourage residents to actively participate in the development of their neighborhoods. This approach aims to enhance the vibrancy and desirability of urban areas, making them more appealing to residents. Venn's innovative model has positively impacted tens of thousands of individuals across its operational cities.
Laguna Health
Seed Round in 2021
Laguna Health employs AI-powered conversational intelligence combined with clinical protocols to assist care managers. This enables more efficient and consistent care responses, improving patient outcomes while enhancing productivity for care teams.
Perception Point
Series B in 2021
Perception Point LTD is a cybersecurity technology company based in Tel Aviv, Israel, specializing in advanced threat detection and response. The company offers a cloud-based platform that safeguards organizations from cyber threats by monitoring and preventing attacks across various enterprise collaboration channels, including email, web, and cloud services. Its innovative approach allows direct access to a computer system's CPU, enabling the detection and prevention of threats before they can be exploited. Perception Point serves a diverse range of industries, including finance, healthcare, and education, providing comprehensive solutions to protect sensitive data and networks from phishing and other malicious activities.
Mend specializes in open-source software (OSS) lifecycle management solutions, offering a comprehensive cloud-based platform designed to manage the OSS lifecycle effectively. Their flagship product integrates seamlessly with development environments and DevOps pipelines, enabling real-time detection of open-source libraries that may pose security or compliance risks. Mend provides actionable remediation paths to resolve identified issues quickly and enforces automated policies to streamline the fixing process. The platform supports over 200 programming languages and continuously monitors multiple open-source vulnerability databases, ensuring that users are informed of potential risks while minimizing false positives. Founded in 2011 and headquartered in New York, Mend maintains additional offices in Boston, Givatayim, the United Kingdom, and Switzerland.
Tylko is a direct-to-consumer brand specializing in high-quality, customizable shelving solutions designed to enhance home organization. The company operates a digital-first marketplace that allows customers to design perfectly fitting furniture for their specific spaces. Utilizing an augmented reality tool and an online configurator, Tylko simplifies the shopping experience, enabling users to visualize products in their homes before making a purchase. With a focus on ease of assembly and doorstep delivery, Tylko aims to provide a seamless experience for customers seeking practical and stylish storage solutions.
Variantyx
Series C in 2021
Variantyx Inc. is a biotechnology company headquartered in Framingham, Massachusetts, that specializes in whole genome sequencing-based diagnostic testing. Founded in 2014, the company offers a comprehensive platform that includes its Genomic Unity® test, which identifies and reports all major types of genetic variants from a single patient sample. This test is designed to diagnose rare inherited disorders, providing a more efficient alternative to traditional genetic testing methods. Variantyx's technology enables hospitals and commercial laboratories to accurately analyze whole genome sequenced data, facilitating a better understanding of a patient's genetic makeup and leading to optimized treatment recommendations. The company's focus on genomic intelligence positions it at the forefront of precision medicine.
Optibus leverages the power of machine learning and optimization algorithms to redefine the way mass-transportation is planned and operated. Optibus’ disruptive technology drive some of the most complex transportation operations worldwide, helping to improve the quality of service, increase efficiencies, save money, and streamline operations.
Finout is a cloud cost management platform designed to help companies optimize and control their cloud expenditures. It offers tools for DevOps, FinOps, Site Reliability Engineering (SRE), and cloud cost observability. The platform enables users to gain insights into their spending on various aspects, including cost of goods sold (COGS) and research and development. By breaking down costs per tenant, Finout allows finance and development teams to better understand their bills and unit economics. This comprehensive approach empowers organizations to regain control over their cloud costs, facilitating more informed decision-making and cost reduction from multiple perspectives.
Medisafe is a digital platform empowering patients to manage their medications effectively. It leverages data science to personalize patient engagement, improving medication adherence by up to 20% as proven in studies. With nearly 5 million users across various devices and an average app rating of 4.7 stars, Medisafe facilitates medication tracking, reminders, and insights for patients and healthcare providers.
ImmuneID
Venture Round in 2021
ImmuneID is a precision immunology company that uses a proprietary platform to identify and therapeutically target millions of antibody interactions that drive immune diseases. The platform enables parallel, multiplexed, and unbiased analyses to develop therapeutics for autoimmunity, severe allergy, oncology, and infectious diseases, and helps researchers observe human immune responses throughout disease progression.
DriveNets
Series B in 2021
DriveNets is a software company founded in 2015 that builds cloud‑native networking solutions for communications service providers. Its flagship product, Network Cloud, disaggregates core and edge infrastructure, replacing traditional hardware with a software‑centric routing stack that runs on standard networking white boxes. The platform delivers a shared data‑path control plane, central management, and northbound interfaces that integrate with third‑party tools. DriveNets supports large‑scale network modernization and AI workloads, enabling telecom operators and data centers to increase agility, cut operating costs, and optimize performance for demanding applications. The company is headquartered in Ra’anana, Israel, with an additional office in Red Bank, New Jersey.
ARMO offers a runtime-powered, Kubernetes-driven, Cloud Security Platform.
ARMO Platform is the only platform that continuously minimizes cloud attack surface based on runtime insights, while actively detecting and responding to cyberattacks with real risk context.
Today there is a vicious cycle of endless back and forth between security and DevOps/Engineering teams. Thousands of security tickets are opened, and an overwhelming number of real time alerts are triggered, but the majority of them are ignored or remain unsolved, and no real security is achieved.
The use of runtime insights and Kubernetes context is crucial for securing the cloud and breaking this cycle.
ARMO Platform uses an eBPF-based runtime sensor to record application behavior and related activities. The recorded baseline is then enriched with relevant context from Kubernetes events, CI/CD data, cloud data and containers’ data. The result is an Application Profile DNA (APDTM), which is the holistic baseline for applications’ normal behavior, configuration, and policies.
Using APDTM, ARMO Platform enables automatic and continuous cloud security posture management to harden cloud-native infrastructure and workloads and to remediate security risks without breaking applications. By detecting and responding to anomalous behaviors, malicious activities and malware, ARMO cloud detection & response (CDR) protects workloads from cyberattacks at runtime. It instantly detects and responds to them without flooding teams with alerts.
ARMO Platform enables DevOps, security, and platform teams to eliminate the security noise in their clusters from thousands of irrelevant alerts and focus on the most important and exploitable threats. This allows them to shift from managing hypothetical security issues to mitigating actual risks and providing them with the means to remediate them.
ARMO Platform protects any type of cloud and Kubernetes deployments: managed, on-premises, and air-gapped.
ARMO is an open-source-driven company and the creator of Kubescape, a leading open-source Kubernetes security project, now an official CNCF project. Kubescape is deployed and tested across over 100K clusters in environments as small as a few workloads, and up to enterprise scales with over 50K running workloads.
TScan Therapeutics
Series C in 2021
TScan Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering and developing T cell receptor (TCR) engineered T cell therapies for cancer treatment. Its primary focus is on liquid tumors, with lead therapy candidates TSC-100 and TSC-101 aimed at addressing hematologic malignancies by targeting residual leukemia and preventing relapse following hematopoietic stem cell transplantation. In addition to its liquid tumor programs, TScan is advancing multiplexed TCR-T therapy candidates to tackle various solid tumors. The company employs a unique platform that identifies previously uncharacterized shared T cell antigens and assesses off-target TCR interactions, which supports the creation of TCR-T therapies with reduced off-target effects. Founded in 2018 and headquartered in Waltham, Massachusetts, TScan Therapeutics aims to transform cancer treatment through innovative T cell therapies.
Founded in 2019, Swimm develops software for onboarding and training developers. Its platform generates up-to-date internal documentation within integrated development environments, enhancing knowledge sharing among developer teams.
Graphcore
Series E in 2020
Graphcore is a hardware systems company that develops intelligent processing units to accelerate machine learning. It designs IPUs and offers IPU-Accelerator cards that plug into servers to accelerate training and inference, and IPU-Appliance products that deliver higher performance for inference and training workloads. Founded in 2016 and headquartered in Bristol, United Kingdom, the company maintains additional locations in Palo Alto, London, Oslo, and Beijing. Its IPU architecture enables running current machine learning models orders of magnitude faster across various servers and processors, supporting a range of AI workloads.
BrainsGate
Series F in 2020
BrainsGate is a medical device company that develops therapies for central nervous system diseases, focusing on acute ischemic stroke. Its platform uses electrical stimulation of the spheno‑palatine ganglion (SPG) via a miniature electrode implanted in the roof of the mouth. The procedure is minimally invasive, performed at bedside under local anesthesia, and is designed to increase cerebral blood flow. The company has completed several clinical studies, including the ImPACT‑1 pilot, a 300‑patient randomized controlled trial, and is currently conducting the ImpACT‑24b pivotal study. Founded in 2000, BrainsGate is headquartered in Caesarea, Israel.
Logz.io provides an intelligent, scalable machine data analytics and open-source log management platform designed for monitoring modern applications. Built on ELK and Grafana, the cloud-native platform combines machine data analysis with artificial intelligence to help engineers, system administrators, and developers monitor, troubleshoot, secure, and optimize mission-critical environments. It enables users to derive value from large volumes of machine data through comprehensive open-source tooling within a unified platform.
AI21 Labs
Series A in 2020
AI21 Labs is an Israeli artificial intelligence company that develops generative AI and large language models along with tools to understand and generate natural language. Founded in 2017 and based in Tel Aviv-Yafo, it provides AI-based writing and reading assistance that understands context and meaning, including a writing companion that can rephrase text to convey the intended message and generate summaries. The company's tools help users read more efficiently, analyze and visualize complex knowledge structures, and apply deep learning and NLP to transform writing and comprehension for businesses and individuals.
Zapata Computing
Series B in 2020
Zapata Computing, Inc. is a quantum software company that specializes in developing innovative computing solutions tailored for industrial and commercial applications. Founded in 2017 and headquartered in Boston, Massachusetts, with an additional office in Toronto, the company emerged from Harvard University and is driven by a team of scientists, including Alán Aspuru-Guzik. Zapata offers Orquestra, a software platform that enables the composition of quantum workflows using a YAML-compatible language, facilitating tasks across both quantum and classical hardware. Its solutions are hardware-agnostic and cater to various sectors, including finance, healthcare, pharmaceuticals, transportation, logistics, energy, and more. Equipped to address complex challenges, Zapata Computing focuses on simulation, optimization, and machine learning, helping enterprise organizations harness the power of quantum technology to enhance their operations.
HomeThrive
Series A in 2020
HomeThrive offers care management services for elderly individuals, combining digital platforms with expert coaching and personal assistance. It aims to help older adults live independently at home while reducing the burden on family caregivers.
Founded in 2017, Nexite operates a platform that enhances physical retail by providing real-time item-level insights. Its key offerings include tiny, battery-free NanoBT tags that enable inventory tracking, transparency, and business intelligence from manufacturing to the customer's home. This empowers retailers and brands to create new revenue streams, improve stock management, and enhance shopping experiences.
Frontegg
Seed Round in 2020
Frontegg LTD. is a Tel-Aviv-based company that specializes in developing a user management platform aimed at enabling software as a service (SaaS) businesses. Founded in 1982, Frontegg provides a comprehensive solution that allows SaaS companies to easily integrate and manage essential user infrastructure, from basic authentication to complex multi-tenancy and fine-grained authorization. Its platform facilitates rapid integration into existing web applications with minimal coding, supporting a variety of frontend and backend frameworks. Frontegg also offers features such as a self-service admin portal, subscription enforcement, and single sign-on capabilities, enhancing the user experience for both personal and organizational accounts. By embedding its interfaces within applications, Frontegg provides a customer-facing management interface while equipping developers with powerful SDKs and APIs to maintain full control over their data.
keepMED Ltd. is a medical technology company based in Rishon Le Zion, Israel, dedicated to developing innovative solutions for the treatment of Obstructive Sleep Apnea (OSA). Founded in 2012 and formerly known as Ninox Medical Ltd., the company has created keePAP, a wearable device designed to address the challenges associated with OSA. This device features a lightweight and unobtrusive nasal interface paired with a compact, battery-operated control unit, allowing for effective management of upper airway obstruction during sleep. Through its focus on disruptive technology, keepMED aims to improve the quality of life for individuals affected by this common sleep disorder.
Zapata Computing
Venture Round in 2020
Zapata Computing, Inc. is a quantum software company that specializes in developing innovative computing solutions tailored for industrial and commercial applications. Founded in 2017 and headquartered in Boston, Massachusetts, with an additional office in Toronto, the company emerged from Harvard University and is driven by a team of scientists, including Alán Aspuru-Guzik. Zapata offers Orquestra, a software platform that enables the composition of quantum workflows using a YAML-compatible language, facilitating tasks across both quantum and classical hardware. Its solutions are hardware-agnostic and cater to various sectors, including finance, healthcare, pharmaceuticals, transportation, logistics, energy, and more. Equipped to address complex challenges, Zapata Computing focuses on simulation, optimization, and machine learning, helping enterprise organizations harness the power of quantum technology to enhance their operations.
Tomorrow.io
Series C in 2020
Tomorrow.io develops a SaaS weather intelligence platform that provides real-time, location-specific weather forecasts tailored to industries affected by weather. The platform helps organizations predict business impacts of weather, streamline communication, and optimize operations to improve efficiency and margins. It combines traditional meteorology data with signals from wireless networks, connected vehicles, satellites, street cameras, and other sources to deliver micro-forecast information. It serves clients across sectors worldwide, enabling countries, businesses, and individuals to manage weather-related challenges and improve decision-making. The company operates in North America, Latin America, Europe, and Asia.
Applicaster
Series D in 2020
Applicaster Ltd. is a technology company that offers a cloud-based platform for app development and content distribution, primarily aimed at broadcasters and media companies. Its Zapp platform provides a flexible and modular solution for launching and maintaining video applications, enabling users to create direct-to-consumer media experiences across various devices. The platform supports a wide range of functionalities, allowing for the integration of third-party services like video players and analytics tools. Applicaster's solutions enhance audience engagement through interactive features and provide tools for mobile TV applications and content management. Founded in 2009 and headquartered in Tel Aviv, Israel, the company operates additional offices in New York, Miami, Los Angeles, and London, serving a global clientele that includes major media players. Through its innovative offerings, Applicaster helps clients streamline their operations, reduce costs, and deliver improved media experiences to millions of viewers worldwide.
Zerto is a company that specializes in providing enterprise-class disaster recovery and business continuity software solutions. Founded in 2009 and headquartered in Boston, Massachusetts with additional offices globally, Zerto focuses on keeping IT infrastructure running continuously for both enterprises and cloud environments. Its flagship product, Zerto Virtual Replication, enables the protection, recovery, and migration of applications across various cloud and virtualized data centers. The company's BC/DR Platform offers disaster recovery as a service for public, private, and hybrid clouds, catering to industries such as healthcare, legal, and financial services.
Founded in 2016, D-ID specializes in AI-driven video content creation. Its platform uses artificial intelligence to generate dynamic videos from images, text, and audio, enabling businesses to produce scalable, personalized narratives cost-effectively without traditional video production teams.
Alike is a digital healthcare company focused on empowering patients to monitor their health conditions effectively. Utilizing an AI-based system, Alike leverages medical records, crowdsourcing, and big data to provide personalized insights for individuals with similar health profiles. This innovative approach aims to enhance patient outcomes and transform healthcare by enabling users to take an active role in managing their health, ultimately leading to substantial improvements in their quality of life.
Visby Medical
Series D in 2020
Visby Medical is a diagnostics company developing PCR-based testing devices and a mobile-enabled health care platform for infectious diseases. Its device platform enables PCR-based diagnostics with results in under 30 minutes and requires no additional instruments or maintenance, supporting point-of-care testing during a single visit. The company pursues a human-centric, technology-first approach to device development and also provides services related to health information, risk assessment, electronic medical records, data privacy and security, data analytics, and remote medical advice for governments, national-level NGOs, and private health providers. Founded in 2008 and based in San Jose, California, Visby Medical aims to improve patient outcomes by enabling rapid, accurate tests at the point of care.
Komodor
Seed Round in 2020
Komodor is a platform that automates Kubernetes operations. It ingests daily Kubernetes events, tracks deployments, configurations, and code changes, correlating them with cluster status for clear understanding of system events.
CyberMDX Technologies Inc., established in 2016 and headquartered in New York, specializes in medical cybersecurity. It offers a cloud-based solution, CyberMDX, which provides real-time visibility, protection, and operational insights for connected healthcare devices. The platform identifies and assesses vulnerabilities, detects and responds to threats, and ensures compliance, all while integrating seamlessly with existing environments. CyberMDX aims to safeguard patient safety and hospital operational continuity by preventing cyber incidents and mitigating risks associated with medical device security.
Developer of a hospitality management platform that transforms restaurants into fully mobile, cloud-based operations. The platform offers a truly mobile point-of-sale system controlling aspects like contactless pay and ordering, delivery, curbside pick-up, guest management, kitchen display, business intelligence, shift management, increasing efficiency, profitability, and customer satisfaction.
Via Transportation Inc. is a company that develops innovative public mobility solutions, focusing on on-demand and pre-scheduled transit. Founded in 2012 and headquartered in New York, Via serves a diverse range of clients, including public transit agencies, cities, universities, corporations, and school districts. The company's mobile app connects passengers traveling in the same direction, allowing them to share premium vehicles and enhancing the efficiency of public transit systems. Via aims to transform traditional, rigid transit systems into dynamic networks by integrating its technology with existing public transportation infrastructure. This approach not only reduces operational costs and traffic congestion but also minimizes single-occupancy trips and carbon emissions, providing more accessible and environmentally friendly transit options. Via operates both in the United States and Europe through partnerships, including a joint venture with Mercedes-Benz Vans.